Stimuli-responsive nanoparticles for targeting the tumor microenvironment

Journal of Controlled Release : Official Journal of the Controlled Release Society
Jinzhi DuShuming Nie

Abstract

One of the most challenging and clinically important goals in nanomedicine is to deliver imaging and therapeutic agents to solid tumors. Here we discuss the recent design and development of stimuli-responsive smart nanoparticles for targeting the common attributes of solid tumors such as their acidic and hypoxic microenvironments. This class of stimuli-responsive nanoparticles is inactive during blood circulation and under normal physiological conditions, but is activated by acidic pH, enzymatic up-regulation, or hypoxia once they extravasate into the tumor microenvironment. The nanoparticles are often designed to first "navigate" the body's vascular system, "dock" at the tumor sites, and then "activate" for action inside the tumor interstitial space. They combine the favorable biodistribution and pharmacokinetic properties of nanodelivery vehicles and the rapid diffusion and penetration properties of smaller drug cargos. By targeting the broad tumor habitats rather than tumor-specific receptors, this strategy has the potential to overcome the tumor heterogeneity problem and could be used to design diagnostic and therapeutic nanoparticles for a broad range of solid tumors.

References

Jan 1, 1983·Cancer Metastasis Reviews·G H Heppner, B E Miller
Sep 12, 1995·Proceedings of the National Academy of Sciences of the United States of America·T SagaJ N Weinstein
Jun 20, 1997·International Journal of Cancer. Journal International Du Cancer·T AbeM Ogawa
Apr 29, 1998·Matrix Biology : Journal of the International Society for Matrix Biology·T A GiambernardiR J Klebe
Apr 12, 2002·Molecular Therapy : the Journal of the American Society of Gene Therapy·David OupickyLeonard W Seymour
May 7, 2002·Nature Reviews. Cancer·Mikala Egeblad, Zena Werb
Jul 26, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Eun Seong LeeYou Han Bae
Aug 23, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Eun Seong LeeYou Han Bae
Jun 2, 2004·Nature Reviews. Cancer·J Martin Brown, William R Wilson
Nov 2, 2004·Nature Reviews. Cancer·Robert A Gatenby, Robert J Gillies
Dec 17, 2004·Proceedings of the National Academy of Sciences of the United States of America·Tao JiangRoger Y Tsien
Mar 2, 2005·Nature Reviews. Cancer·Mauro Ferrari
Mar 15, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Eun Seong LeeYou Han Bae
Mar 30, 2005·Nano Letters·Eun Seong LeeYou Han Bae
Dec 3, 2005·Cancer Research·Anne T CollinsNorman J Maitland
Jan 10, 2006·Biomacromolecules·Vijay A SethuramanYou Han Bae
Feb 21, 2006·Cancer Research·Max S WichaGabriela Dontu
Mar 2, 2006·Journal of the National Cancer Institute·Matthew R DreherAshutosh Chilkoti
Apr 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Yana K ReshetnyakDonald M Engelman
Jan 24, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Vijay A Sethuraman, You Han Bae
Apr 19, 2007·Annual Review of Biomedical Engineering·Shuming NieJonathan W Simons
May 8, 2007·Proceedings of the National Academy of Sciences of the United States of America·Oleg A AndreevYana K Reshetnyak
May 15, 2007·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Gee Young LeeYoungro Byun
Sep 19, 2007·Proceedings of the National Academy of Sciences of the United States of America·Derek W BartlettMark E Davis
Sep 25, 2007·Nature Biotechnology·Hak Soo ChoiJohn V Frangioni
Jan 12, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Haiqing YinYou Han Bae
Jun 10, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Eun Seong LeeYou Han Bae
Jun 24, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Eun Seong LeeYou Han Bae
Jul 26, 2008·Nature Nanotechnology·Dan PeerRobert Langer
Aug 14, 2008·Proceedings of the National Academy of Sciences of the United States of America·Stephanie E A GrattonJoseph M DeSimone
Sep 2, 2008·Nature Reviews. Drug Discovery·Mark E DavisDong M Shin
Oct 3, 2008·Proceedings of the National Academy of Sciences of the United States of America·Yana K ReshetnyakDonald M Engelman
Apr 11, 2009·Oncology Reports·M W RoomiA Niedzwiecki
Apr 16, 2009·Molecular Pharmaceutics·Emily Gullotti, Yoon Yeo
May 23, 2009·Science·Matthew G Vander HeidenCraig B Thompson
Jul 29, 2009·Chemistry & Biology·Damien ThéveninDonald M Engelman
Jul 30, 2009·Biomacromolecules·Volker Mailänder, Katharina Landfester
Nov 7, 2009·Nature Nanotechnology·Hak Soo ChoiJohn V Frangioni
Feb 18, 2010·Proceedings of the National Academy of Sciences of the United States of America·Emilia S OlsonRoger Y Tsien
Feb 18, 2010·Proceedings of the National Academy of Sciences of the United States of America·Quyen T NguyenRoger Y Tsien
Feb 18, 2010·Proceedings of the National Academy of Sciences of the United States of America·Oleg A AndreevYana K Reshetnyak

❮ Previous
Next ❯

Citations

Mar 17, 2016·ACS Nano·Anna E CzaparNicole F Steinmetz
May 29, 2016·Advanced Drug Delivery Reviews·Kai YangZhuang Liu
May 27, 2016·Chemical Communications : Chem Comm·Thavasyappan ThambiDoo Sung Lee
May 28, 2016·Pharmaceutical Research·Mihaela AldeaIoan Stefan Florian
Jul 9, 2016·ACS Applied Materials & Interfaces·Qiuju HanZhiyuan Hu
Oct 27, 2016·ACS Applied Materials & Interfaces·Subhajit GhoshSurajit Ghosh
Jun 16, 2017·Journal of Microencapsulation·Jingyuan Xiong, Huile Gao
Sep 25, 2017·International Journal of Molecular Sciences·Li KongAlexander Kros
Apr 17, 2018·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Ya-Ru ZhangJun Wang
Sep 4, 2018·Chemical Communications : Chem Comm·Jie PanHao Wang
Oct 3, 2018·Therapeutic Delivery·Priya Sahadevan Syamala, Rekha Mannemcherril Ramesan
Nov 23, 2019·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Yucong SongZhigang Xie
Jan 11, 2020·ChemMedChem·Yucong SongZhigang Xie
Oct 4, 2019·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Xu Zhen, Xiqun Jiang
Jun 17, 2020·Journal of Biophotonics·Eran A BarnoyDror Fixler
Sep 25, 2020·Expert Opinion on Drug Delivery·Joydeb Majumder, Tamara Minko
Jan 27, 2019·Therapeutic Delivery·Gizem BorAnan Yaghmur
Apr 17, 2019·Biomedical Microdevices·Sara BusattoJoy Wolfram
Mar 13, 2020·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Nicholas E Wojtynek, Aaron M Mohs
Feb 21, 2017·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Jianhua ZhuQunwei Xu
Jan 28, 2019·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Yi-Hong GongJie Liu
Aug 5, 2020·Drug Delivery and Translational Research·Malobika Chakravarty, Amisha Vora
Sep 3, 2020·International Journal of Molecular Sciences·Horrick Sharma, Somrita Mondal
Sep 4, 2018·Journal of Applied Polymer Science·Angela M WagnerNicholas A Peppas
Aug 15, 2019·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Jin HeXintao Shuai
Aug 30, 2018·Biomaterials Research·Saji UthamanIn-Kyu Park
Apr 10, 2019·Polymers·DaeYong LeeYeu-Chun Kim
Feb 7, 2018·Antibodies·Andrew T LucasWilliam C Zamboni

❮ Previous
Next ❯

Related Concepts

Related Feeds

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.